RT Journal Article
SR Electronic
T1 Advances in autosomal dominant polycystic kidney disease—2014 and beyond
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP 545
OP 556
DO 10.3949/ccjm.81gr.14001
VO 81
IS 9
A1 Braun, William E.
YR 2014
UL http://www.ccjm.org/content/81/9/545.abstract
AB Autosomal dominant polycystic kidney disease (ADPKD), which frequently leads to end-stage renal disease, currently has no specific drug therapies. Better understanding of its pathogenesis and recent clinical trials have led to more accurate diagnosis of the disease and its manifestations, as well as to promising new approaches to treatment.